148 related articles for article (PubMed ID: 8306525)
1. Urinary trypsin inhibitor (UTI) and fragments derived from UTI by limited proteolysis efficiently inhibit tumor cell invasion.
Kobayashi H; Shinohara H; Ohi H; Sugimura M; Terao T; Fujie M
Clin Exp Metastasis; 1994 Mar; 12(2):117-28. PubMed ID: 8306525
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the soluble and the tumor cell receptor-bound plasmin by urinary trypsin inhibitor and subsequent effects on tumor cell invasion and metastasis.
Kobayashi H; Shinohara H; Takeuchi K; Itoh M; Fujie M; Saitoh M; Terao T
Cancer Res; 1994 Feb; 54(3):844-9. PubMed ID: 8306348
[TBL] [Abstract][Full Text] [Related]
3. Effects of urinary trypsin inhibitor on the invasion of reconstituted basement membranes by ovarian cancer cells.
Kobayashi H; Fujie M; Shinohara H; Ohi H; Sugimura M; Terao T
Int J Cancer; 1994 May; 57(3):378-84. PubMed ID: 8168999
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of tumor cell invasion through matrigel by a peptide derived from the domain II region in urinary trypsin inhibition.
Kobayashi H; Gotoh J; Kanayama N; Hirashima Y; Terao T; Sugino D
Cancer Res; 1995 May; 55(9):1847-52. PubMed ID: 7728751
[TBL] [Abstract][Full Text] [Related]
5. A bifunctional hybrid molecule of the amino-terminal fragment of urokinase and domain II of bikunin efficiently inhibits tumor cell invasion and metastasis.
Kobayashi H; Sugino D; She MY; Ohi H; Hirashima Y; Shinohara H; Fujie M; Shibata K; Terao T
Eur J Biochem; 1998 May; 253(3):817-26. PubMed ID: 9654084
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of a conjugate between human urokinase and urinary trypsin inhibitor on tumor cell invasion in vitro.
Kobayashi H; Gotoh J; Hirashima Y; Fujie M; Sugino D; Terao T
J Biol Chem; 1995 Apr; 270(14):8361-6. PubMed ID: 7713945
[TBL] [Abstract][Full Text] [Related]
7. [Mechanism of tumor cell-induced extracellular matrix degradation--inhibition of cell-surface proteolytic activity might have a therapeutic effect on tumor cell invasion and metastasis].
Kobayashi H
Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug; 48(8):623-32. PubMed ID: 8808830
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of metastasis of Lewis lung carcinoma by urinary trypsin inhibitor in experimental and spontaneous metastasis models.
Kobayashi H; Shinohara H; Fujie M; Gotoh J; Itoh M; Takeuchi K; Terao T
Int J Cancer; 1995 Nov; 63(3):455-62. PubMed ID: 7591248
[TBL] [Abstract][Full Text] [Related]
9. Urinary trypsin inhibitor efficiently inhibits urokinase production in tumor necrosis factor-stimulated cells.
Kobayashi H; Gotoh J; Terao T
Eur J Cell Biol; 1996 Dec; 71(4):380-6. PubMed ID: 8980909
[TBL] [Abstract][Full Text] [Related]
10. Role of activated protein C in facilitating basement membrane invasion by tumor cells.
Kobayashi H; Moniwa N; Gotoh J; Sugimura M; Terao T
Cancer Res; 1994 Jan; 54(1):261-7. PubMed ID: 8261450
[TBL] [Abstract][Full Text] [Related]
11. The role of cell membrane-associated urinary trypsin inhibitor in tumor cell invasion and metastasis.
Kobayashi H; Terao T
Oncol Rep; 1997; 4(1):65-72. PubMed ID: 21590013
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the cellular binding site for the urinary trypsin inhibitor.
Kobayashi H; Gotoh J; Fujie M; Terao T
J Biol Chem; 1994 Aug; 269(32):20642-7. PubMed ID: 8051163
[TBL] [Abstract][Full Text] [Related]
13. Suppression of invasion and peritoneal carcinomatosis of ovarian cancer cell line by overexpression of bikunin.
Suzuki M; Kobayashi H; Tanaka Y; Hirashima Y; Kanayama N; Takei Y; Saga Y; Suzuki M; Itoh H; Terao T
Int J Cancer; 2003 Apr; 104(3):289-302. PubMed ID: 12569552
[TBL] [Abstract][Full Text] [Related]
14. Saturation of tumour cell surface receptors for urokinase-type plasminogen activator by amino-terminal fragment and subsequent effect on reconstituted basement membranes invasion.
Kobayashi H; Ohi H; Shinohara H; Sugimura M; Fujii T; Terao T; Schmitt M; Goretzki L; Chucholowski N; Jänicke F
Br J Cancer; 1993 Mar; 67(3):537-44. PubMed ID: 8382511
[TBL] [Abstract][Full Text] [Related]
15. Plasmin modulators, aprotinin and anti-catalytic plasmin antibody, efficiently inhibit destruction of bovine vascular endothelial cells by choriocarcinoma cells.
Sugimura M; Kobayashi H; Terao T
Gynecol Oncol; 1994 Mar; 52(3):337-46. PubMed ID: 7512520
[TBL] [Abstract][Full Text] [Related]
16. Inter-alpha-trypsin inhibitor bound to tumor cells is cleaved into the heavy chains and the light chain on the cell surface.
Kobayashi H; Gotoh J; Hirashima Y; Terao T
J Biol Chem; 1996 May; 271(19):11362-7. PubMed ID: 8626690
[TBL] [Abstract][Full Text] [Related]
17. Suppression of urokinase-type plasminogen activator expression from human ovarian cancer cells by urinary trypsin inhibitor.
Kobayashi H; Suzuki M; Sun GW; Hirashima Y; Terao T
Biochim Biophys Acta; 2000 Sep; 1481(2):310-6. PubMed ID: 11018722
[TBL] [Abstract][Full Text] [Related]
18. Amiloride and urinary trypsin inhibitor inhibit urothelial cancer invasion.
Oka N; Okumura Y; Kanayama HO; Izaki H; Okamoto M; Kido H; Kagawa S
Eur Urol; 2003 Dec; 44(6):737-41. PubMed ID: 14644129
[TBL] [Abstract][Full Text] [Related]
19. Generation of cell surface-bound plasmin by cell-associated urokinase-type or secreted tissue-type plasminogen activator: a key event in melanoma cell invasiveness in vitro.
Meissauer A; Kramer MD; Schirrmacher V; Brunner G
Exp Cell Res; 1992 Apr; 199(2):179-90. PubMed ID: 1531956
[TBL] [Abstract][Full Text] [Related]
20. Urinary trypsin inhibitor, a Kunitz-type protease inhibitor, modulates tumor necrosis factor-stimulated activation and translocation of protein kinase C in U937 cells.
Kobayashi H; Sugino D; Terao T
Int J Oncol; 1998 Jan; 12(1):95-105. PubMed ID: 9454892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]